Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study
An amendment to this paper has been published and can be accessed via the original article.
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-06-01
|
| Series: | BMC Pulmonary Medicine |
| Online Access: | https://doi.org/10.1186/s12890-021-01559-7 |